BAJAJ BROKING

Notification close image
No new Notification messages
card image
Seshaasai Technologies Ltd IPO
Apply for the Seshaasai Technologies Ltd IPO through UPI in Just minutes
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

2783

543271

JUBLINGREA

img img img img
No Data Available

Jubilant Ingrevia performance

Today’s low

Today’s high

₹ 683.00 ₹ 694.75
₹ 684.05

52 week low

52 week high

₹ 535.20 ₹ 885.00
₹ 684.05

Open Price

₹ 688.40

Prev. Close

₹ 688.40

Volume (Shares)

40795.00

Total traded value

₹ 279.05

Upper Circuit

₹ 826.05

Lower Circuit

₹ 550.75

info

Jubilant Ingrevia Share Price Update

As of the latest trading session, Jubilant Ingrevia share price is currently at ₹ 687.65, which is down by ₹ -0.75 from its previous closing. Today, the stock has fluctuated between ₹ 683.00 and ₹ 694.75. Over the past year, Jubilant Ingrevia has achieved a return of -12.92 %. In the last month alone, the return has been -0.31 %. Read More...

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

Jubilant Ingrevia fundamentals


  • Market cap (Cr)

    10,902.80

  • P/E Ratio (TTM)

    40.03

  • Beta

    1.08

  • Book Value / share

    157.54

  • Return on equity

    11.24%

  • EPS (TTM)

    17.17

  • Dividend yield

    0.73%

  • Net profit/quarter (Cr)

    44.03

info icon alternate text
  • Market cap (Cr)

    10,910.80

  • P/E Ratio (TTM)

    40.03

  • Beta

    1.01

  • Book Value / share

    157.54

  • Return on equity

    11.24%

  • EPS (TTM)

    17.17

  • Dividend yield

    0.73%

  • Net profit/quarter (Cr)

    44.03

info icon alternate text

Jubilant Ingrevia Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars SEP 2025 (Values in Cr)
Revenue 1043.16
Operating Expense 1005.63
Net Profit 44.03
Net Profit Margin (%) 4.22
Earnings Per Share (EPS) 2.77
EBITDA 112.09
Effective Tax Rate (%) 25.95
Particulars JUN 2025 (Values in Cr)
Revenue 964.55
Operating Expense 904.76
Net Profit 59.01
Net Profit Margin (%) 6.11
Earnings Per Share (EPS) 3.70
EBITDA 132.48
Effective Tax Rate (%) 25.69
Particulars MAR 2025 (Values in Cr)
Revenue 952.40
Operating Expense 896.63
Net Profit 89.87
Net Profit Margin (%) 9.43
Earnings Per Share (EPS) 5.64
EBITDA 163.48
Effective Tax Rate (%) 18.99
Particulars DEC 2024 (Values in Cr)
Revenue 984.11
Operating Expense 916.42
Net Profit 80.60
Net Profit Margin (%) 8.19
Earnings Per Share (EPS) 5.06
EBITDA 158.07
Effective Tax Rate (%) 23.65
Particulars SEP 2024 (Values in Cr)
Revenue 989.16
Operating Expense 931.85
Net Profit 60.18
Net Profit Margin (%) 6.08
Earnings Per Share (EPS) 3.78
EBITDA 136.83
Effective Tax Rate (%) 27.05
Particulars MAR 2025 (Values in Cr)
Revenue 3880.95
Operating Expense 3678.88
Net Profit 263.42
Net Profit Margin (%) 6.78
Earnings Per Share (EPS) 16.54
EBITDA 555.75
Effective Tax Rate (%) 23.28
Particulars MAR 2024 (Values in Cr)
Revenue 3952.14
Operating Expense 3783.77
Net Profit 162.45
Net Profit Margin (%) 4.11
Earnings Per Share (EPS) 10.20
EBITDA 438.43
Effective Tax Rate (%) 32.02
Particulars MAR 2023 (Values in Cr)
Revenue 4528.39
Operating Expense 4223.01
Net Profit 253.41
Net Profit Margin (%) 5.59
Earnings Per Share (EPS) 15.91
EBITDA 525.56
Effective Tax Rate (%) 31.05
Particulars MAR 2022 (Values in Cr)
Revenue 4831.21
Operating Expense 4213.76
Net Profit 452.25
Net Profit Margin (%) 9.36
Earnings Per Share (EPS) 28.39
EBITDA 841.84
Effective Tax Rate (%) 33.04
Particulars MAR 2021 (Values in Cr)
Revenue 663.77
Operating Expense 602.90
Net Profit 38.59
Net Profit Margin (%) 5.81
Earnings Per Share (EPS) 14.75
EBITDA 86.34
Effective Tax Rate (%) 30.51
Particulars MAR 2025 (Values in Cr)
Book Value / Share 185.11
ROE % 8.87
ROCE % 10.87
Total Debt to Total Equity 0.27
EBITDA Margin 13.33
Particulars MAR 2024 (Values in Cr)
Book Value / Share 173.27
ROE % 6.77
ROCE % 9.59
Total Debt to Total Equity 0.21
EBITDA Margin 11.04
Particulars MAR 2023 (Values in Cr)
Book Value / Share 167.72
ROE % 12.06
ROCE % 15.59
Total Debt to Total Equity 0.13
EBITDA Margin 12.16
Particulars MAR 2022 (Values in Cr)
Book Value / Share 153.06
ROE % 21.89
ROCE % 27.99
Total Debt to Total Equity 0.18
EBITDA Margin 17.44
Particulars MAR 2021 (Values in Cr)
Book Value / Share 120.73
ROE % 6.60
ROCE % 7.67
Total Debt to Total Equity 0.29
EBITDA Margin 17.50
Particulars MAR 2025 (Values in Cr)
Book Value / Share 153.24
ROE % 11.24
ROCE % 12.55
Total Debt to Total Equity 0.36
EBITDA Margin 14.10
Particulars MAR 2024 (Values in Cr)
Book Value / Share 141.08
ROE % 7.37
ROCE % 10.10
Total Debt to Total Equity 0.34
EBITDA Margin 11.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 135.52
ROE % 12.24
ROCE % 15.08
Total Debt to Total Equity 0.27
EBITDA Margin 11.53
Particulars MAR 2022 (Values in Cr)
Book Value / Share 124.50
ROE % 25.42
ROCE % 29.22
Total Debt to Total Equity 0.35
EBITDA Margin 17.32
Particulars MAR 2021 (Values in Cr)
Book Value / Share 98.94
ROE % 6.04
ROCE % 6.43
Total Debt to Total Equity 0.50
EBITDA Margin 14.84
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 98.72
Total Assets 5031.76
Total Liabilities 5031.76
Total Equity 2927.07
Share Outstanding 159281139
Price to Book Ratio 4.24
Return on Assets (%) 4.99
Return on Capital (%) 6.82
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 79.59
Total Assets 4731.89
Total Liabilities 4731.89
Total Equity 2737.47
Share Outstanding 159281139
Price to Book Ratio 3.20
Return on Assets (%) 3.86
Return on Capital (%) 5.27
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 84.58
Total Assets 4258.87
Total Liabilities 4258.87
Total Equity 2666.23
Share Outstanding 159281139
Price to Book Ratio 2.65
Return on Assets (%) 7.22
Return on Capital (%) 10.04
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 48.52
Total Assets 3797.14
Total Liabilities 3797.14
Total Equity 2433.12
Share Outstanding 158969139
Price to Book Ratio 3.61
Return on Assets (%) 12.55
Return on Capital (%) 17.91
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 116.60
Total Assets 3378.52
Total Liabilities 3378.52
Total Equity 1922.93
Share Outstanding 159281139
Price to Book Ratio 2.64
Return on Assets (%) 1.60
Return on Capital (%) 2.2
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 50.84
Total Assets 4520.72
Total Liabilities 4520.72
Total Equity 2440.87
Share Outstanding 159281139
Price to Book Ratio 4.24
Return on Assets (%) 5.82
Return on Capital (%) 8.16
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 19.51
Total Assets 4340.40
Total Liabilities 4340.40
Total Equity 2247.05
Share Outstanding 159281139
Price to Book Ratio 3.20
Return on Assets (%) 3.74
Return on Capital (%) 5.28
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 36.52
Total Assets 4058.39
Total Liabilities 4058.39
Total Equity 2158.57
Share Outstanding 159281139
Price to Book Ratio 2.65
Return on Assets (%) 6.24
Return on Capital (%) 9.18
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 24.42
Total Assets 3652.13
Total Liabilities 3652.13
Total Equity 1983.04
Share Outstanding 159281139
Price to Book Ratio 3.61
Return on Assets (%) 12.38
Return on Capital (%) 18.78
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 85.64
Total Assets 3239.96
Total Liabilities 3239.96
Total Equity 1575.85
Share Outstanding 159281139
Price to Book Ratio 2.64
Return on Assets (%) 1.19
Return on Capital (%) 1.74
Particulars MAR 2025 (Values in Cr)
Net Income 343.62
Cash from Operations 587.67
Cash from Investing -392.81
Cash from Financing -128.75
Net change in Cash -9.42
Free Cash Flow 953.46
Particulars MAR 2024 (Values in Cr)
Net Income 267.61
Cash from Operations 475.98
Cash from Investing -568.77
Cash from Financing 144.13
Net change in Cash 6.05
Free Cash Flow 1044.35
Particulars MAR 2023 (Values in Cr)
Net Income 436.71
Cash from Operations 539.84
Cash from Investing -471.89
Cash from Financing 41.59
Net change in Cash 35.11
Free Cash Flow 1021.22
Particulars MAR 2022 (Values in Cr)
Net Income 708.94
Cash from Operations 580.84
Cash from Investing -71.85
Cash from Financing -417.75
Net change in Cash -35.73
Free Cash Flow 810.98
Particulars MAR 2021 (Values in Cr)
Net Income 77.38
Cash from Operations 123.78
Cash from Investing -43.65
Cash from Financing -72.36
Net change in Cash -3.64
Free Cash Flow 151.33
Particulars MAR 2025 (Values in Cr)
Net Income 343.36
Cash from Operations 514.92
Cash from Investing -210.54
Cash from Financing -208.42
Net change in Cash 22.36
Free Cash Flow 731.18
Particulars MAR 2024 (Values in Cr)
Net Income 238.99
Cash from Operations 426.88
Cash from Investing -463.66
Cash from Financing 64.06
Net change in Cash -5.95
Free Cash Flow 768.02
Particulars MAR 2023 (Values in Cr)
Net Income 367.58
Cash from Operations 517.30
Cash from Investing -475.28
Cash from Financing 32.80
Net change in Cash 3.15
Free Cash Flow 963.34
Particulars MAR 2022 (Values in Cr)
Net Income 675.47
Cash from Operations 697.92
Cash from Investing -220.75
Cash from Financing -410.23
Net change in Cash -44.18
Free Cash Flow 922.54
Particulars MAR 2021 (Values in Cr)
Net Income 55.53
Cash from Operations 114.76
Cash from Investing -29.40
Cash from Financing -70.20
Net change in Cash 4.57
Free Cash Flow 142.27
Company Name Price P/E P/B Market Cap 52 Week Low/High
ATUL LTD 5752.10 31.23 2.86 16935.19 4882.00 / 7793.00
BASF INDIA LTD 4067.75 47.73 4.64 17607.52 4041.00 / 5944.30
ORIENTAL AROMATICS LIMITED 301.80 103.71 1.53 1015.66 252.40 / 487.95
DEEPAK FERTILISERS & PETROCHEM 1320.80 16.94 2.55 16673.49 888.25 / 1776.95
Company Name Price P/E P/B Market Cap 52 Week Low/High
ADVANCE PETROCHEMICALS LTD. 209.60 381.09 5.07 18.86 168.70 / 275.95
ATUL LTD 5752.10 34.67 2.91 16935.19 4882.00 / 7793.00
BASF INDIA LTD 4067.75 45.77 4.61 17607.52 4041.00 / 5944.30
ORIENTAL AROMATICS LIMITED 301.80 32.38 1.47 1015.66 252.40 / 487.95

Jubilant Ingrevia shareholding pattern

Holding

25.77%
45.22%
5.96%
23.03%
7.08%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

Transparent Pricing and 360° Services

Choose a Plan That Suits Your Goals and Needs

greenshadow greenshadow redshadow pricing-pack Freedom Pack
₹20/order 14.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : FREE

greenshadow greenshadow redshadow pricing-pack

Professional Pack

₹10/order 11.99% p.a. MTF
tick Stock Picks by Research Analysts tick Seamless Onboarding

Subscription Charge : ₹2,500 Yearly

50% Brokerage Savings
greenshadow greenshadow redshadow pricing-pack

Signature

0.2% on Delivery 11.99% p.a. MTF
tick Dedicated Relationship Manager tick Customised Brokerage Support tick Stock Picks by Research Analysts tick Experienced Dealer Support

News

Left Arrow
Right Arrow

Jubilant Ingrevia Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
684.50 -0.56 redarrow
red-green-graph indicator
0 Bearish
16 Bullish
  • 5 Days 700.50
  • 26 Days 699.60
  • 10 Days 703.90
  • 50 Days 698.00
  • 12 Days 703.80
  • 100 Days 703.50
  • 20 Days 701.40
  • 200 Days 700.10
694.80 PIVOT

First Support

679.60

First Resistance

703.60

Second Support

670.80

Second Resistance

718.80

Third Support

655.60

Third Resistance

727.60

RSI

45.24

ADX

15.65

MACD

4.22

Williams % R

-90.41

Commodity Channel Index (CCI)

-17.46

Date

2025-12-04

Week

69335.00

Same Day

48052.00

Month

108834.00

1 Year

1.09

3 Year

0.83

Over 1 Month

-0.31%

down

Over 1 Year

-12.92%

down

Over 3 Months

-5.93%

down

Over 3 Years

8.79%

down

Over 6 Months

-5.87%

down

Over 5 Years

20.70%

down

Jubilant Ingrevia Corporate Actions

Dividend date Dividend amount Dividend type Record date Instrument type
25 Jul 2025 2.5 Final 25 Jul 2025 Equity shares
03 Feb 2025 2.5 Interim 03 Feb 2025 Equity shares
02 Aug 2024 2.5 Final 02 Aug 2024 Equity shares
09 Feb 2024 2.5 Interim 09 Feb 2024 Equity shares
10 Aug 2023 2.5 Final 10 Aug 2023 Equity shares
10 Feb 2023 2.5 Interim 10 Feb 2023 Equity shares
23 Aug 2022 2.5 Final 24 Aug 2022 Equity shares
10 Feb 2022 2.5 Interim 11 Feb 2022 Equity shares
05 Aug 2021 0.35 Final 06 Aug 2021 Equity shares
Dividend date Dividend amount Dividend type Record date Instrument type
25 Jul 2025 2.5 Final 25 Jul 2025 Equity shares
03 Feb 2025 2.5 Interim 03 Feb 2025 Equity shares
02 Aug 2024 2.5 Final 02 Aug 2024 Equity shares
09 Feb 2024 2.5 Interim 09 Feb 2024 Equity shares
10 Aug 2023 2.5 Final 10 Aug 2023 Equity shares
10 Feb 2023 2.5 Interim 10 Feb 2023 Equity shares
23 Aug 2022 2.5 Final 24 Aug 2022 Equity shares
10 Feb 2022 2.5 Interim 11 Feb 2022 Equity shares
05 Aug 2021 0.35 Final 06 Aug 2021 Equity shares

Jubilant Ingrevia Share Price

Jubilant Ingrevia Limited (Formerly known as Jubilant LSI Limited) was incorporated as a Public Limited Company on October 23, 2019 in Uttar Pradesh. The name of the Company was changed from 'Jubilant LSI Limited' to 'Jubilant Ingrevia Limited' on October 16, 2020.

The Company is a global integrated Life Science products and Innovative Solutions provider serving Pharmaceutical, Nutrition, Agrochemical, Consumer and Industrial customers with customised products and solutions that are innovative, cost-effective and conforming to excellent quality standards. The Company is a part of the Jubilant Bhartia Group, a diversified global conglomerate founded by Mr. Shyam S. Bhartia and Mr. Hari S. Bhartia.

Today, the Group has a strong presence in diverse sectors like Pharmaceuticals, Contract Research and Development Services, Proprietary Novel Drugs, Life Science Ingredients, Agri Products, Performance Polymers, Food Service (QSR), Food, Auto, Consulting in Aerospace and Oilfield Services. The Group has four flagships companies listed on Indian Stock Exchanges - Jubilant Ingrevia Limited, Jubilant Pharmova Limited, Jubilant FoodWorks Limited and Jubilant Industries Limited.

The Company's state-of-the-art manufacturing facilities across India offer a range of products and solutions that are innovative, cost
effective and quality driven. It established itself as a single point solution for CDMO services for global Pharmaceutical and Agrochemical companies. It is at present across the value chain like Route design, Process Development, Process Optimisation, Scale-up and Commercial Manufacturing of Advance Intermediates for Pharma and Agro and Actives for Agrochemicals. It is a leading supplier of Ethanol to Oil Marketing Companies (OMCs) for Ethanol Blending Programme (EBP) among standalone distilleries in India.

The Company is engaged in manufacturing and supply of speciality intermediates, nutrition & health solutions and life science chemicals through five manufacturing facilities in India. It offers broad portfolio of high quality ingredient that find application in a wide range of industries. It serves more than 1400 customers in more than 60 countries across the world. The portfolio of the Company is extended to custom research and manufacturing for pharmaceutical and agrochemical customers on an exclusive basis.

The business focuses on three core segments - Speciality Chemicals, Nutrition and Health Solutions and Life Science Chemicals. The Company offer a range of products including straight Nutritional Ingredients like Vitamin B3, Picolinates to premix solutions for animal and human nutrition. The Life Science Chemicals and Speciality Chemicals segments provide complete backward integration giving competitive edge over competitors. The Company is the global largest producer of Niacinamide and amongst Global top two manufacturers of Vitamin B3 and India's largest manufacturer of Vitamin B4. The Company is a Partner of Choice' for more than 400 global customers. It has also embarked on the manufacturing of herbal range of products for animal feed under the brand Phytoshield'.

The Life Science Ingredients (LSI) business of Jubilant Pharmova Limited was demerged into the Company, (Jubilant Ingrevia Limited) through the Scheme of Amalgamation effective from February 1, 2021. Pursuant to Composite Scheme of Arrangement, 5 subsidiary companies of Jubilant Pharmova Limited namely, Jubilant Infrastructure Limited, Jubilant Life Sciences (USA) Inc., Jubilant Life Sciences International Pte. Limited, Jubilant Life Sciences (Shanghai) Limited and Jubilant Life Sciences NV became subsidiaries of the Company effective from the said date.

During FY 2022-23, the Company acquired 37.98% of equity share capital of Mister Veg Foods Private Limited (MVFPL) effective March 16, 2023. It commissioned the 25,000 TPA New Acetic Anhydride Plant in Bharuch, Gujarat.

The Company launched new products by introducing the food-grade Choline Chloride and Choline Bitartrate in FY24. Further, a new agrochemical plant at SEZ Bharuch commissioned in FY 2024. The Phase II of Diketene Derivatives with the addition of 2000 TPA for multiple products was commissioned. A multi-purpose Agro Actives & Intermediate plant in Bharuch and a Diketene Derivatives plant in Gajraula commissioned in FY24.

New plants commissioned for food- and cosmeticgrade niacinamide/niacin facility and Diketene derivatives plants in FY 2025.

Parent organization Jubilant Bhartia Group
NSE symbol JUBLINGREA
Founded 2019
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Jubilant Ingrevia Ltd?

Answer Field

Jubilant Ingrevia Ltd share price is for NSE ₹ 687.65 & for BSE ₹ 687.65 as on Dec 05 2025 01:13 PM.

What is the Market Cap of Jubilant Ingrevia Ltd Share?

Answer Field

The market cap of Jubilant Ingrevia Ltd for NSE ₹ 10,952.97 & for BSE ₹ 10,952.97 as on Dec 05 2025 01:13 PM.

What is the 52 Week High and Low of Jubilant Ingrevia Ltd?

Answer Field

The 52 Week High and Low of Jubilant Ingrevia Ltd for NSE is ₹ 885.00 and ₹ 535.20 and for BSE is ₹ 884.95 and ₹ 556.55.

What is 1 year return for Jubilant Ingrevia Ltd?

Answer Field

The 1 year returns on the stock has been -12.92%.

What is the P/E Ratio of Jubilant Ingrevia Ltd Share?

Answer Field

As on Dec 05 2025 01:13 PM the price-to-earnings (PE) ratio for Jubilant Ingrevia Ltd share is 40.03.

What is the PB ratio of Jubilant Ingrevia Ltd Share?

Answer Field

As on Dec 05 2025 01:13 PM, the price-to-book (PB) ratio for Jubilant Ingrevia Ltd share is 157.54.

How to Buy Jubilant Ingrevia Ltd Share?

Answer Field

You can trade in Jubilant Ingrevia Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Jubilant Ingrevia Ltd Share on Bajaj Broking App?

Answer Field

To buy Jubilant Ingrevia Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Jubilant Ingrevia Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59